| 저자 |
Mi Jung Lee, Young Eun Chon, Hyung Jong Kim, Yu Bum Choi, Seong Gyu Hwang, Kyu Sung Rim, Mi Na Kim, Hana Park, Joo Ho Lee, Yeonjung Ha |
| 초록 |
Weight loss is regarded as a pivotal treatment strategy in both obese and non-obese non-alcoholic fatty liver disease (NAFLD). However, there is a lack of data evaluating whether changes in central obesity affects long-term kidney function in this population. Therefore, we investigated the impact of changes in waist-to-hip ratio (WHR) on adverse kidney outcomes in NAFLD patients using a community-based, prospective cohort with a 12-year follow-up. Among 10,030 participants from the Korean Genome Epidemiology Study, 1,774 NAFLD patients were included in this study. Patients were categorized into three groups according to time-averaged percent changes of WHR (TA-%WHR change), respectively; ≥-5%, <-5% to <5%, ≥5%. Study outcomes were development of chronic kidney disease (CKD). The independent association of TA-%WHR change with CKD development was evaluated in both non-obese NAFLD (body mass index [BMI] <25 kg/m2) and obese NAFLD (BMI ≥25 kg/m2). During a mean follow-up of 108.7 ± 44.5 months, CKD developed in 510 patients (28.7%). In 1,774 NAFLD patients, compared to patients with minimal changes of WHR (<-5% to <5%), patients with reduced WHR of more than 5% had a significantly decreased risk of CKD development (HR=0.300; 95% CI=0.194-0.464; P<0.001). Furthermore, significant risk reduction from decreased WHR (≥-5%) for developing CKD remained still in non-obese NAFLD patients (HR=0.290; 95% CI=0.114-0.736; P=0.01), as well as obese NAFLD patients (HR=0.289; 95% CI=0.175-0.476; P<0.001). This study demonstrated that more than an average of 5% decrease in WHR, a useful anthropometric index of central obesity, significantly reduced the risk of CKD development even in NAFLD patients who are non-obese. It suggests that significant and sustained reduction of central obesity may improve long-term kidney outcomes in patients with NAFLD. |